Apar Gupta, MD
Radiation Oncology · Scottsdale, AZNPI 1407237845
Payments from drug & device makers
Across 98 payments — averaging $56.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GT Medical Technologies, Inc$3K
- Novartis$222
- Novocure Inc.$216
- AstraZeneca$209
- AbbVie$197
- Steris Corporation$186
- plus $2K from 28 others
What the payments were for
- Travel & lodging$2,00036%
- Food & beverage$3,58064%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GT Medical Technologies, Inc | 12 | $2,815 |
| Novartis | 10 | $222 |
| Novocure Inc. | 5 | $216 |
| AstraZeneca | 8 | $209 |
| AbbVie | 9 | $197 |
| Steris Corporation | 1 | $186 |
| Sobi, Inc | 7 | $182 |
| Telix Pharmaceuticals | 2 | $162 |
| Genmab U.S., Inc. | 5 | $155 |
| Daiichi Sankyo Inc. | 4 | $116 |
| Monteris Medical Corporation | 1 | $114 |
| Seagen Inc. | 1 | $106 |
| Merck | 4 | $105 |
| Icotec Medical Inc. | 1 | $104 |
| Bayer | 4 | $70 |
| Pfizer | 3 | $68 |
| Progenics Pharmaceuticals, Inc. | 2 | $53 |
| Stemline Therapeutics Inc. | 2 | $50 |
| Davol Inc. | 1 | $50 |
| EMD Serono, Inc. | 2 | $42 |
| Tersera Therapeutics LLC | 1 | $37 |
| Puma Biotechnology, Inc. | 1 | $30 |
| Ipsen Biopharmaceuticals, Inc | 1 | $30 |
| Adaptive Biotechnologies Corporation | 1 | $28 |
| Eisai Inc. | 1 | $27 |
| Syndax Pharmaceuticals, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $26 |
| Rigel Pharmaceuticals, Inc. | 1 | $26 |
| Johnson & Johnson | 1 | $26 |
| Biocon Biologics Inc | 1 | $23 |
| Agios Pharmaceuticals, Inc. | 1 | $21 |
| Springworks Therapeutics, Inc. | 1 | $20 |
| Legend Biotech USA Inc. | 1 | $20 |
| Boston Scientific | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GammaTile$2,495
- ILLUCCIX$278
- TRUFREEZE$186
- Optune$135
- Neuroblate$114
- TUKYSA$106
- icotec BlackArmor Spine System$104
How this compares
$5,580 in reported general payments places this provider in the 65th percentile of 138 radiation oncology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 14 | $234 |
| Dexamethasone | 11 | $230 |
| Tamsulosin Hcl | 19 | $166 |
| Pilocarpine Hcl | 12 | $103 |
| Methylprednisolone | 13 | $89 |
| Ondansetron Hcl | 11 | $69 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Scottsdale
- Chi ZhangScottsdale$495K
- Terence SioScottsdale$221K
- Carlos VargasScottsdale$179K
- Aaron AmbradScottsdale$30K
- Vershalee ShuklaScottsdale$19K
- Gordon GradoScottsdale$12K
- Gregory MaggassScottsdale$11K
- Scott TannehillScottsdale$8K
- Randa TaoScottsdale$6K
- Ammoren DohmScottsdale$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.